Similarly, patients in the LO group with variant KRAS showed significantly higher CSS for CRC-related death compared with patients with wild-type KRAS tumors (sHR, 1.06 [95% CI, 1.02-1.09]; P = .002) (Figure 3). The gene discussed is KRAS; the disease is colorectal carcinoma.